Global Small Molecule API Market by End User (Ambulatory Surgical Centers, Hospitals), by Type (Captive, Contract), by Application (Metabolic, Ophthalmology, Cardiovascular, Dermatology), by Product (Chemical Process, Biological Procedure) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Up Market Research published a new report titled “Small Molecule API Market research report which is segmented by End User (Ambulatory Surgical Centers, Hospitals), by Type (Captive, Contract), by Application (Metabolic, Ophthalmology, Cardiovascular, Dermatology), by Product (Chemical Process, Biological Procedure), By Players/Companies Gland Pharma Limited, Celgene Corporation, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Gilead Sciences Inc., BASF SE, Evonik Industries AG, AstraZeneca Plc., Pfizer Inc., Boehringer Ingelheim International GmbH, Cambrex Corporation, Recipharm AB, Albemarle Corporation, Aurinia Pharmaceuticals Inc., Aesica Pharmaceuticals Ltd., AbbVie Contract Manufacturing, Sun Pharmaceutical Industries Ltd., CordenPharma International., Lonza, Patheon, Bayer AG, Sanofi S.A., Piramal Pharma Solutions, Glenmark Pharmaceuticals Limited, Siegfried AG”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
| Report Attributes | Report Details |
| Report Title | Small Molecule API Market Research Report |
| By End User | Ambulatory Surgical Centers, Hospitals |
| By Type | Captive, Contract |
| By Application | Metabolic, Ophthalmology, Cardiovascular, Dermatology |
| By Product | Chemical Process, Biological Procedure |
| By Companies | Gland Pharma Limited, Celgene Corporation, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Gilead Sciences Inc., BASF SE, Evonik Industries AG, AstraZeneca Plc., Pfizer Inc., Boehringer Ingelheim International GmbH, Cambrex Corporation, Recipharm AB, Albemarle Corporation, Aurinia Pharmaceuticals Inc., Aesica Pharmaceuticals Ltd., AbbVie Contract Manufacturing, Sun Pharmaceutical Industries Ltd., CordenPharma International., Lonza, Patheon, Bayer AG, Sanofi S.A., Piramal Pharma Solutions, Glenmark Pharmaceuticals Limited, Siegfried AG |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 219 |
| Number of Tables & Figures | 154 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Small Molecule API Market Report Segments:
The market is segmented by End User (Ambulatory Surgical Centers, Hospitals), by Type (Captive, Contract), by Application (Metabolic, Ophthalmology, Cardiovascular, Dermatology), by Product (Chemical Process, Biological Procedure).
Some of the companies that are profiled in this report are:
- Gland Pharma Limited
- Celgene Corporation
- Baxter International Inc.
- Teva Pharmaceutical Industries Ltd.
- Gilead Sciences Inc.
- BASF SE
- Evonik Industries AG
- AstraZeneca Plc.
- Pfizer Inc.
- Boehringer Ingelheim International GmbH
- Cambrex Corporation
- Recipharm AB
- Albemarle Corporation
- Aurinia Pharmaceuticals Inc.
- Aesica Pharmaceuticals Ltd.
- AbbVie Contract Manufacturing
- Sun Pharmaceutical Industries Ltd.
- CordenPharma International.
- Lonza
- Patheon
- Bayer AG
- Sanofi S.A.
- Piramal Pharma Solutions
- Glenmark Pharmaceuticals Limited
- Siegfried AG
Small Molecule API Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Small Molecule API Market
Overview of the regional outlook of the Small Molecule API Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Small Molecule API Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Small Molecule API Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
1. Ambulatory Surgical Centers
2. Hospitals
7. By Type:1. Captive
2. Contract
8. By Application:1. Metabolic
2. Ophthalmology
3. Cardiovascular
4. Dermatology
9. By Product:1. Chemical Process
2. Biological Procedure
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Small Molecule API Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Small Molecule API Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Small Molecule API Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Small Molecule API Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Small Molecule API Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Small Molecule API Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Small Molecule API Market Size & Forecast, 2018-2028
4.5.1 Small Molecule API Market Size and Y-o-Y Growth
4.5.2 Small Molecule API Market Absolute $ Opportunity
Chapter 5 Global Small Molecule API Market Analysis and Forecast by End User
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by End User
5.1.2 Basis Point Share (BPS) Analysis by End User
5.1.3 Absolute $ Opportunity Assessment by End User
5.2 Small Molecule API Market Size Forecast by End User
5.2.1 Ambulatory Surgical Centers
5.2.2 Hospitals
5.3 Market Attractiveness Analysis by End User
Chapter 6 Global Small Molecule API Market Analysis and Forecast by Type
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Type
6.1.2 Basis Point Share (BPS) Analysis by Type
6.1.3 Absolute $ Opportunity Assessment by Type
6.2 Small Molecule API Market Size Forecast by Type
6.2.1 Captive
6.2.2 Contract
6.3 Market Attractiveness Analysis by Type
Chapter 7 Global Small Molecule API Market Analysis and Forecast by Application
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Application
7.1.2 Basis Point Share (BPS) Analysis by Application
7.1.3 Absolute $ Opportunity Assessment by Application
7.2 Small Molecule API Market Size Forecast by Application
7.2.1 Metabolic
7.2.2 Ophthalmology
7.2.3 Cardiovascular
7.2.4 Dermatology
7.3 Market Attractiveness Analysis by Application
Chapter 8 Global Small Molecule API Market Analysis and Forecast by Product
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities by Product
8.1.2 Basis Point Share (BPS) Analysis by Product
8.1.3 Absolute $ Opportunity Assessment by Product
8.2 Small Molecule API Market Size Forecast by Product
8.2.1 Chemical Process
8.2.2 Biological Procedure
8.3 Market Attractiveness Analysis by Product
Chapter 9 Global Small Molecule API Market Analysis and Forecast by Region
9.1 Introduction
9.1.1 Key Market Trends & Growth Opportunities by Region
9.1.2 Basis Point Share (BPS) Analysis by Region
9.1.3 Absolute $ Opportunity Assessment by Region
9.2 Small Molecule API Market Size Forecast by Region
9.2.1 North America
9.2.2 Europe
9.2.3 Asia Pacific
9.2.4 Latin America
9.2.5 Middle East & Africa (MEA)
9.3 Market Attractiveness Analysis by Region
Chapter 10 Coronavirus Disease (COVID-19) Impact
10.1 Introduction
10.2 Current & Future Impact Analysis
10.3 Economic Impact Analysis
10.4 Government Policies
10.5 Investment Scenario
Chapter 11 North America Small Molecule API Analysis and Forecast
11.1 Introduction
11.2 North America Small Molecule API Market Size Forecast by Country
11.2.1 U.S.
11.2.2 Canada
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 North America Small Molecule API Market Size Forecast by End User
11.6.1 Ambulatory Surgical Centers
11.6.2 Hospitals
11.7 Basis Point Share (BPS) Analysis by End User
11.8 Absolute $ Opportunity Assessment by End User
11.9 Market Attractiveness Analysis by End User
11.10 North America Small Molecule API Market Size Forecast by Type
11.10.1 Captive
11.10.2 Contract
11.11 Basis Point Share (BPS) Analysis by Type
11.12 Absolute $ Opportunity Assessment by Type
11.13 Market Attractiveness Analysis by Type
11.14 North America Small Molecule API Market Size Forecast by Application
11.14.1 Metabolic
11.14.2 Ophthalmology
11.14.3 Cardiovascular
11.14.4 Dermatology
11.15 Basis Point Share (BPS) Analysis by Application
11.16 Absolute $ Opportunity Assessment by Application
11.17 Market Attractiveness Analysis by Application
11.18 North America Small Molecule API Market Size Forecast by Product
11.18.1 Chemical Process
11.18.2 Biological Procedure
11.19 Basis Point Share (BPS) Analysis by Product
11.20 Absolute $ Opportunity Assessment by Product
11.21 Market Attractiveness Analysis by Product
Chapter 12 Europe Small Molecule API Analysis and Forecast
12.1 Introduction
12.2 Europe Small Molecule API Market Size Forecast by Country
12.2.1 Germany
12.2.2 France
12.2.3 Italy
12.2.4 U.K.
12.2.5 Spain
12.2.6 Russia
12.2.7 Rest of Europe
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Europe Small Molecule API Market Size Forecast by End User
12.6.1 Ambulatory Surgical Centers
12.6.2 Hospitals
12.7 Basis Point Share (BPS) Analysis by End User
12.8 Absolute $ Opportunity Assessment by End User
12.9 Market Attractiveness Analysis by End User
12.10 Europe Small Molecule API Market Size Forecast by Type
12.10.1 Captive
12.10.2 Contract
12.11 Basis Point Share (BPS) Analysis by Type
12.12 Absolute $ Opportunity Assessment by Type
12.13 Market Attractiveness Analysis by Type
12.14 Europe Small Molecule API Market Size Forecast by Application
12.14.1 Metabolic
12.14.2 Ophthalmology
12.14.3 Cardiovascular
12.14.4 Dermatology
12.15 Basis Point Share (BPS) Analysis by Application
12.16 Absolute $ Opportunity Assessment by Application
12.17 Market Attractiveness Analysis by Application
12.18 Europe Small Molecule API Market Size Forecast by Product
12.18.1 Chemical Process
12.18.2 Biological Procedure
12.19 Basis Point Share (BPS) Analysis by Product
12.20 Absolute $ Opportunity Assessment by Product
12.21 Market Attractiveness Analysis by Product
Chapter 13 Asia Pacific Small Molecule API Analysis and Forecast
13.1 Introduction
13.2 Asia Pacific Small Molecule API Market Size Forecast by Country
13.2.1 China
13.2.2 Japan
13.2.3 South Korea
13.2.4 India
13.2.5 Australia
13.2.6 South East Asia (SEA)
13.2.7 Rest of Asia Pacific (APAC)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Asia Pacific Small Molecule API Market Size Forecast by End User
13.6.1 Ambulatory Surgical Centers
13.6.2 Hospitals
13.7 Basis Point Share (BPS) Analysis by End User
13.8 Absolute $ Opportunity Assessment by End User
13.9 Market Attractiveness Analysis by End User
13.10 Asia Pacific Small Molecule API Market Size Forecast by Type
13.10.1 Captive
13.10.2 Contract
13.11 Basis Point Share (BPS) Analysis by Type
13.12 Absolute $ Opportunity Assessment by Type
13.13 Market Attractiveness Analysis by Type
13.14 Asia Pacific Small Molecule API Market Size Forecast by Application
13.14.1 Metabolic
13.14.2 Ophthalmology
13.14.3 Cardiovascular
13.14.4 Dermatology
13.15 Basis Point Share (BPS) Analysis by Application
13.16 Absolute $ Opportunity Assessment by Application
13.17 Market Attractiveness Analysis by Application
13.18 Asia Pacific Small Molecule API Market Size Forecast by Product
13.18.1 Chemical Process
13.18.2 Biological Procedure
13.19 Basis Point Share (BPS) Analysis by Product
13.20 Absolute $ Opportunity Assessment by Product
13.21 Market Attractiveness Analysis by Product
Chapter 14 Latin America Small Molecule API Analysis and Forecast
14.1 Introduction
14.2 Latin America Small Molecule API Market Size Forecast by Country
14.2.1 Brazil
14.2.2 Mexico
14.2.3 Rest of Latin America (LATAM)
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 Latin America Small Molecule API Market Size Forecast by End User
14.6.1 Ambulatory Surgical Centers
14.6.2 Hospitals
14.7 Basis Point Share (BPS) Analysis by End User
14.8 Absolute $ Opportunity Assessment by End User
14.9 Market Attractiveness Analysis by End User
14.10 Latin America Small Molecule API Market Size Forecast by Type
14.10.1 Captive
14.10.2 Contract
14.11 Basis Point Share (BPS) Analysis by Type
14.12 Absolute $ Opportunity Assessment by Type
14.13 Market Attractiveness Analysis by Type
14.14 Latin America Small Molecule API Market Size Forecast by Application
14.14.1 Metabolic
14.14.2 Ophthalmology
14.14.3 Cardiovascular
14.14.4 Dermatology
14.15 Basis Point Share (BPS) Analysis by Application
14.16 Absolute $ Opportunity Assessment by Application
14.17 Market Attractiveness Analysis by Application
14.18 Latin America Small Molecule API Market Size Forecast by Product
14.18.1 Chemical Process
14.18.2 Biological Procedure
14.19 Basis Point Share (BPS) Analysis by Product
14.20 Absolute $ Opportunity Assessment by Product
14.21 Market Attractiveness Analysis by Product
Chapter 15 Middle East & Africa (MEA) Small Molecule API Analysis and Forecast
15.1 Introduction
15.2 Middle East & Africa (MEA) Small Molecule API Market Size Forecast by Country
15.2.1 Saudi Arabia
15.2.2 South Africa
15.2.3 UAE
15.2.4 Rest of Middle East & Africa (MEA)
15.3 Basis Point Share (BPS) Analysis by Country
15.4 Absolute $ Opportunity Assessment by Country
15.5 Market Attractiveness Analysis by Country
15.6 Middle East & Africa (MEA) Small Molecule API Market Size Forecast by End User
15.6.1 Ambulatory Surgical Centers
15.6.2 Hospitals
15.7 Basis Point Share (BPS) Analysis by End User
15.8 Absolute $ Opportunity Assessment by End User
15.9 Market Attractiveness Analysis by End User
15.10 Middle East & Africa (MEA) Small Molecule API Market Size Forecast by Type
15.10.1 Captive
15.10.2 Contract
15.11 Basis Point Share (BPS) Analysis by Type
15.12 Absolute $ Opportunity Assessment by Type
15.13 Market Attractiveness Analysis by Type
15.14 Middle East & Africa (MEA) Small Molecule API Market Size Forecast by Application
15.14.1 Metabolic
15.14.2 Ophthalmology
15.14.3 Cardiovascular
15.14.4 Dermatology
15.15 Basis Point Share (BPS) Analysis by Application
15.16 Absolute $ Opportunity Assessment by Application
15.17 Market Attractiveness Analysis by Application
15.18 Middle East & Africa (MEA) Small Molecule API Market Size Forecast by Product
15.18.1 Chemical Process
15.18.2 Biological Procedure
15.19 Basis Point Share (BPS) Analysis by Product
15.20 Absolute $ Opportunity Assessment by Product
15.21 Market Attractiveness Analysis by Product
Chapter 16 Competition Landscape
16.1 Small Molecule API Market: Competitive Dashboard
16.2 Global Small Molecule API Market: Market Share Analysis, 2019
16.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
16.3.1 Gland Pharma Limited
16.3.2 Celgene Corporation
16.3.3 Baxter International Inc.
16.3.4 Teva Pharmaceutical Industries Ltd.
16.3.5 Gilead Sciences Inc.
16.3.6 BASF SE
16.3.7 Evonik Industries AG
16.3.8 AstraZeneca Plc.
16.3.9 Pfizer Inc.
16.3.10 Boehringer Ingelheim International GmbH
16.3.11 Cambrex Corporation
16.3.12 Recipharm AB
16.3.13 Albemarle Corporation
16.3.14 Aurinia Pharmaceuticals Inc.
16.3.15 Aesica Pharmaceuticals Ltd.
16.3.16 AbbVie Contract Manufacturing
16.3.17 Sun Pharmaceutical Industries Ltd.
16.3.18 CordenPharma International.
16.3.19 Lonza
16.3.20 Patheon
16.3.21 Bayer AG
16.3.22 Sanofi S.A.
16.3.23 Piramal Pharma Solutions
16.3.24 Glenmark Pharmaceuticals Limited
16.3.25 Siegfried AG
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Small Molecule API Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Small Molecule API Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Small Molecule API Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Small Molecule API Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Small Molecule API Market Size & Forecast, 2018-2028
4.5.1 Small Molecule API Market Size and Y-o-Y Growth
4.5.2 Small Molecule API Market Absolute $ Opportunity
Chapter 5 Global Small Molecule API Market Analysis and Forecast by End User
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by End User
5.1.2 Basis Point Share (BPS) Analysis by End User
5.1.3 Absolute $ Opportunity Assessment by End User
5.2 Small Molecule API Market Size Forecast by End User
5.2.1 Ambulatory Surgical Centers
5.2.2 Hospitals
5.3 Market Attractiveness Analysis by End User
Chapter 6 Global Small Molecule API Market Analysis and Forecast by Type
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Type
6.1.2 Basis Point Share (BPS) Analysis by Type
6.1.3 Absolute $ Opportunity Assessment by Type
6.2 Small Molecule API Market Size Forecast by Type
6.2.1 Captive
6.2.2 Contract
6.3 Market Attractiveness Analysis by Type
Chapter 7 Global Small Molecule API Market Analysis and Forecast by Application
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Application
7.1.2 Basis Point Share (BPS) Analysis by Application
7.1.3 Absolute $ Opportunity Assessment by Application
7.2 Small Molecule API Market Size Forecast by Application
7.2.1 Metabolic
7.2.2 Ophthalmology
7.2.3 Cardiovascular
7.2.4 Dermatology
7.3 Market Attractiveness Analysis by Application
Chapter 8 Global Small Molecule API Market Analysis and Forecast by Product
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities by Product
8.1.2 Basis Point Share (BPS) Analysis by Product
8.1.3 Absolute $ Opportunity Assessment by Product
8.2 Small Molecule API Market Size Forecast by Product
8.2.1 Chemical Process
8.2.2 Biological Procedure
8.3 Market Attractiveness Analysis by Product
Chapter 9 Global Small Molecule API Market Analysis and Forecast by Region
9.1 Introduction
9.1.1 Key Market Trends & Growth Opportunities by Region
9.1.2 Basis Point Share (BPS) Analysis by Region
9.1.3 Absolute $ Opportunity Assessment by Region
9.2 Small Molecule API Market Size Forecast by Region
9.2.1 North America
9.2.2 Europe
9.2.3 Asia Pacific
9.2.4 Latin America
9.2.5 Middle East & Africa (MEA)
9.3 Market Attractiveness Analysis by Region
Chapter 10 Coronavirus Disease (COVID-19) Impact
10.1 Introduction
10.2 Current & Future Impact Analysis
10.3 Economic Impact Analysis
10.4 Government Policies
10.5 Investment Scenario
Chapter 11 North America Small Molecule API Analysis and Forecast
11.1 Introduction
11.2 North America Small Molecule API Market Size Forecast by Country
11.2.1 U.S.
11.2.2 Canada
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 North America Small Molecule API Market Size Forecast by End User
11.6.1 Ambulatory Surgical Centers
11.6.2 Hospitals
11.7 Basis Point Share (BPS) Analysis by End User
11.8 Absolute $ Opportunity Assessment by End User
11.9 Market Attractiveness Analysis by End User
11.10 North America Small Molecule API Market Size Forecast by Type
11.10.1 Captive
11.10.2 Contract
11.11 Basis Point Share (BPS) Analysis by Type
11.12 Absolute $ Opportunity Assessment by Type
11.13 Market Attractiveness Analysis by Type
11.14 North America Small Molecule API Market Size Forecast by Application
11.14.1 Metabolic
11.14.2 Ophthalmology
11.14.3 Cardiovascular
11.14.4 Dermatology
11.15 Basis Point Share (BPS) Analysis by Application
11.16 Absolute $ Opportunity Assessment by Application
11.17 Market Attractiveness Analysis by Application
11.18 North America Small Molecule API Market Size Forecast by Product
11.18.1 Chemical Process
11.18.2 Biological Procedure
11.19 Basis Point Share (BPS) Analysis by Product
11.20 Absolute $ Opportunity Assessment by Product
11.21 Market Attractiveness Analysis by Product
Chapter 12 Europe Small Molecule API Analysis and Forecast
12.1 Introduction
12.2 Europe Small Molecule API Market Size Forecast by Country
12.2.1 Germany
12.2.2 France
12.2.3 Italy
12.2.4 U.K.
12.2.5 Spain
12.2.6 Russia
12.2.7 Rest of Europe
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Europe Small Molecule API Market Size Forecast by End User
12.6.1 Ambulatory Surgical Centers
12.6.2 Hospitals
12.7 Basis Point Share (BPS) Analysis by End User
12.8 Absolute $ Opportunity Assessment by End User
12.9 Market Attractiveness Analysis by End User
12.10 Europe Small Molecule API Market Size Forecast by Type
12.10.1 Captive
12.10.2 Contract
12.11 Basis Point Share (BPS) Analysis by Type
12.12 Absolute $ Opportunity Assessment by Type
12.13 Market Attractiveness Analysis by Type
12.14 Europe Small Molecule API Market Size Forecast by Application
12.14.1 Metabolic
12.14.2 Ophthalmology
12.14.3 Cardiovascular
12.14.4 Dermatology
12.15 Basis Point Share (BPS) Analysis by Application
12.16 Absolute $ Opportunity Assessment by Application
12.17 Market Attractiveness Analysis by Application
12.18 Europe Small Molecule API Market Size Forecast by Product
12.18.1 Chemical Process
12.18.2 Biological Procedure
12.19 Basis Point Share (BPS) Analysis by Product
12.20 Absolute $ Opportunity Assessment by Product
12.21 Market Attractiveness Analysis by Product
Chapter 13 Asia Pacific Small Molecule API Analysis and Forecast
13.1 Introduction
13.2 Asia Pacific Small Molecule API Market Size Forecast by Country
13.2.1 China
13.2.2 Japan
13.2.3 South Korea
13.2.4 India
13.2.5 Australia
13.2.6 South East Asia (SEA)
13.2.7 Rest of Asia Pacific (APAC)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Asia Pacific Small Molecule API Market Size Forecast by End User
13.6.1 Ambulatory Surgical Centers
13.6.2 Hospitals
13.7 Basis Point Share (BPS) Analysis by End User
13.8 Absolute $ Opportunity Assessment by End User
13.9 Market Attractiveness Analysis by End User
13.10 Asia Pacific Small Molecule API Market Size Forecast by Type
13.10.1 Captive
13.10.2 Contract
13.11 Basis Point Share (BPS) Analysis by Type
13.12 Absolute $ Opportunity Assessment by Type
13.13 Market Attractiveness Analysis by Type
13.14 Asia Pacific Small Molecule API Market Size Forecast by Application
13.14.1 Metabolic
13.14.2 Ophthalmology
13.14.3 Cardiovascular
13.14.4 Dermatology
13.15 Basis Point Share (BPS) Analysis by Application
13.16 Absolute $ Opportunity Assessment by Application
13.17 Market Attractiveness Analysis by Application
13.18 Asia Pacific Small Molecule API Market Size Forecast by Product
13.18.1 Chemical Process
13.18.2 Biological Procedure
13.19 Basis Point Share (BPS) Analysis by Product
13.20 Absolute $ Opportunity Assessment by Product
13.21 Market Attractiveness Analysis by Product
Chapter 14 Latin America Small Molecule API Analysis and Forecast
14.1 Introduction
14.2 Latin America Small Molecule API Market Size Forecast by Country
14.2.1 Brazil
14.2.2 Mexico
14.2.3 Rest of Latin America (LATAM)
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 Latin America Small Molecule API Market Size Forecast by End User
14.6.1 Ambulatory Surgical Centers
14.6.2 Hospitals
14.7 Basis Point Share (BPS) Analysis by End User
14.8 Absolute $ Opportunity Assessment by End User
14.9 Market Attractiveness Analysis by End User
14.10 Latin America Small Molecule API Market Size Forecast by Type
14.10.1 Captive
14.10.2 Contract
14.11 Basis Point Share (BPS) Analysis by Type
14.12 Absolute $ Opportunity Assessment by Type
14.13 Market Attractiveness Analysis by Type
14.14 Latin America Small Molecule API Market Size Forecast by Application
14.14.1 Metabolic
14.14.2 Ophthalmology
14.14.3 Cardiovascular
14.14.4 Dermatology
14.15 Basis Point Share (BPS) Analysis by Application
14.16 Absolute $ Opportunity Assessment by Application
14.17 Market Attractiveness Analysis by Application
14.18 Latin America Small Molecule API Market Size Forecast by Product
14.18.1 Chemical Process
14.18.2 Biological Procedure
14.19 Basis Point Share (BPS) Analysis by Product
14.20 Absolute $ Opportunity Assessment by Product
14.21 Market Attractiveness Analysis by Product
Chapter 15 Middle East & Africa (MEA) Small Molecule API Analysis and Forecast
15.1 Introduction
15.2 Middle East & Africa (MEA) Small Molecule API Market Size Forecast by Country
15.2.1 Saudi Arabia
15.2.2 South Africa
15.2.3 UAE
15.2.4 Rest of Middle East & Africa (MEA)
15.3 Basis Point Share (BPS) Analysis by Country
15.4 Absolute $ Opportunity Assessment by Country
15.5 Market Attractiveness Analysis by Country
15.6 Middle East & Africa (MEA) Small Molecule API Market Size Forecast by End User
15.6.1 Ambulatory Surgical Centers
15.6.2 Hospitals
15.7 Basis Point Share (BPS) Analysis by End User
15.8 Absolute $ Opportunity Assessment by End User
15.9 Market Attractiveness Analysis by End User
15.10 Middle East & Africa (MEA) Small Molecule API Market Size Forecast by Type
15.10.1 Captive
15.10.2 Contract
15.11 Basis Point Share (BPS) Analysis by Type
15.12 Absolute $ Opportunity Assessment by Type
15.13 Market Attractiveness Analysis by Type
15.14 Middle East & Africa (MEA) Small Molecule API Market Size Forecast by Application
15.14.1 Metabolic
15.14.2 Ophthalmology
15.14.3 Cardiovascular
15.14.4 Dermatology
15.15 Basis Point Share (BPS) Analysis by Application
15.16 Absolute $ Opportunity Assessment by Application
15.17 Market Attractiveness Analysis by Application
15.18 Middle East & Africa (MEA) Small Molecule API Market Size Forecast by Product
15.18.1 Chemical Process
15.18.2 Biological Procedure
15.19 Basis Point Share (BPS) Analysis by Product
15.20 Absolute $ Opportunity Assessment by Product
15.21 Market Attractiveness Analysis by Product
Chapter 16 Competition Landscape
16.1 Small Molecule API Market: Competitive Dashboard
16.2 Global Small Molecule API Market: Market Share Analysis, 2019
16.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
16.3.1 Gland Pharma Limited
16.3.2 Celgene Corporation
16.3.3 Baxter International Inc.
16.3.4 Teva Pharmaceutical Industries Ltd.
16.3.5 Gilead Sciences Inc.
16.3.6 BASF SE
16.3.7 Evonik Industries AG
16.3.8 AstraZeneca Plc.
16.3.9 Pfizer Inc.
16.3.10 Boehringer Ingelheim International GmbH
16.3.11 Cambrex Corporation
16.3.12 Recipharm AB
16.3.13 Albemarle Corporation
16.3.14 Aurinia Pharmaceuticals Inc.
16.3.15 Aesica Pharmaceuticals Ltd.
16.3.16 AbbVie Contract Manufacturing
16.3.17 Sun Pharmaceutical Industries Ltd.
16.3.18 CordenPharma International.
16.3.19 Lonza
16.3.20 Patheon
16.3.21 Bayer AG
16.3.22 Sanofi S.A.
16.3.23 Piramal Pharma Solutions
16.3.24 Glenmark Pharmaceuticals Limited
16.3.25 Siegfried AG
Segments Covered in the Report
The global Small Molecule API market has been segmented based on
By End User
The global Small Molecule API market has been segmented based on
By End User
- Ambulatory Surgical Centers
- Hospitals
- Captive
- Contract
- Metabolic
- Ophthalmology
- Cardiovascular
- Dermatology
- Chemical Process
- Biological Procedure
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Gland Pharma Limited
- Celgene Corporation
- Baxter International Inc.
- Teva Pharmaceutical Industries Ltd.
- Gilead Sciences Inc.
- BASF SE
- Evonik Industries AG
- AstraZeneca Plc.
- Pfizer Inc.
- Boehringer Ingelheim International GmbH
- Cambrex Corporation
- Recipharm AB
- Albemarle Corporation
- Aurinia Pharmaceuticals Inc.
- Aesica Pharmaceuticals Ltd.
- AbbVie Contract Manufacturing
- Sun Pharmaceutical Industries Ltd.
- CordenPharma International.
- Lonza
- Patheon
- Bayer AG
- Sanofi S.A.
- Piramal Pharma Solutions
- Glenmark Pharmaceuticals Limited
- Siegfried AG
Our Clients
Related Reports
Some other reports from this category!
